Quick Question Archives
- What assay should be deleted from the thrombosis risk factor profile? - 33 votes - open
- How do you measure unfractionated heparin? - 37 votes - open
- How do you measure the anti-Xa DOACs rivaroxaban or apixaban? - 34 votes - open
- What single agonist is your first choice to measure platelet response to aspirin? - 59 votes - open
- A patient experiences soft tissue bleeding and poor wound healing. The PT, PTT, and TT are normal. What followup profile do you recommend? - 60 votes - open
- The resident orders a thrombosis risk profile on an inpatient being treated for PE. How do you respond? - 28 votes - open
- Case: A 3-YOA female with normal PT and prolonged PTT and no bleeding. What is the most likely deficiency? - 80 votes - open
- How are you managing the blue-top tube shortage? - 29 votes - open
- What is the favorite near-patient viscoelastic test of US anesthesiologists? - 16 votes - open
- Which factor deficiency causes the smallest risk of bleeding? - 50 votes - open
- Which cell is the main cause of thrombo-inflammation in a COVID-19 infection? - 45 votes - open
- What is the trademark name of the dabigatran reversal agent? - 26 votes - open
- What is the more common name for Flaujeac factor? - 28 votes - open
- What test do you employ to validate the need for Andexanet Alfa to reverse DOAC overdose? - 35 votes - open
- A 2 YO experiences frequent joint bleeds. PT: 22s; PTT: 29s; fibrinogen 280 mg/dL. What do you do next? - 57 votes - open
